Trending

Deep Dive

European digital health innovation

European digital health innovation

Healthcare and the pharmaceutical industry are redefining their roles for the modern age as digital health tech radically

X

European digital health innovation

https://pharmaphorum.com/digital/european-digital-health-innovation/

CAR-Ts – a new weapon in the fight against cancer

CAR-Ts – a new weapon in the fight against cancer

CAR-T – or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer. CAR-T therapies

X

CAR-Ts – a new weapon in the fight against cancer

https://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/

How to achieve digital success in pharma’s communications

How to achieve digital success in pharma’s communications

Demystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for

X

How to achieve digital success in pharma’s communications

https://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/

Future-proofing pharma with a multichannel approach to sales and marketing

Future-proofing pharma with a multichannel approach to sales and marketing

Deploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and

X

Future-proofing pharma with a multichannel approach to sales and marketing

https://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/

Non-adherence: pharma’s final financial frontier

Non-adherence: pharma’s final financial frontier

No other industry would tolerate avoidable annual losses of $637 billion, but that’s exactly what pharma is doing by not investing in adherence. Now is the time to start recovering that revenue.

X

Non-adherence: pharma’s final financial frontier

https://pharmaphorum.com/views-and-analysis/non-adherence-pharmas-final-financial-frontier/

Uncovering patient-centred insights

Uncovering patient-centred insights

There are good reasons why patient centricity has become such a well-used term within the pharmaceutical industry. But, says Kantar Health’s Linda VerPlanck, the research approaches underpinning it must be able to deliver transformational insights that can, in turn, improve real-world outcomes.

X

Uncovering patient-centred insights

https://pharmaphorum.com/views-and-analysis/uncovering-patient-centred-insights/

The user experience in your clinical trials: it really matters

The user experience in your clinical trials: it really matters

Everybody knows the current clinical trial model is broken. But it’s not technology that will fix it –

X

The user experience in your clinical trials: it really matters

https://pharmaphorum.com/r-d/views-analysis-r-d/the-user-experience-in-your-clinical-trials-it-really-matters/

Pharma must live and breathe patient centricity

Pharma must live and breathe patient centricity

Patient-centric programmes that ignore the ‘BREATHE’ principles will fail to hit the mark and leave patients behind, according

X

Pharma must live and breathe patient centricity

https://pharmaphorum.com/views-analysis-patients/pharma-must-live-and-breathe-patient-centricity/

Five practical steps to patient centricity

Five practical steps to patient centricity

How can pharma marketers put patients at the centre of product strategy and help improve their conditions?

X

Five practical steps to patient centricity

https://pharmaphorum.com/views-and-analysis/five-practical-steps-to-patient-centricity/

1 2 3 4 5 >»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com